Auration Biotech - AU-935's Unit Acquisition

Auration Biotech - AU-935 raised a round of funding on February 03, 2017. Investors include Astellas Pharma.

Auration Biotech's vision is to develop novel therapeutics that restore or maintain hearing. The company is working on two different programs, as well as other on stealth mode. The AU-935 drug, could …

Articles about Auration Biotech - AU-935's Unit Acquisition: